CompoSecure (NASDAQ:CMPO) Given “Buy” Rating at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of CompoSecure (NASDAQ:CMPOFree Report) in a research note published on Monday,Benzinga reports. Needham & Company LLC currently has a $16.00 price target on the stock.

Several other analysts have also commented on the company. Lake Street Capital lifted their price objective on CompoSecure from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their price target on CompoSecure from $8.00 to $12.00 and gave the company a “neutral” rating in a research note on Tuesday, August 20th. Compass Point upped their price target on shares of CompoSecure from $11.50 to $14.50 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Bank of America raised their price objective on shares of CompoSecure from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, Benchmark upped their target price on shares of CompoSecure from $12.00 to $17.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $15.79.

Get Our Latest Stock Analysis on CMPO

CompoSecure Stock Up 1.5 %

Shares of NASDAQ CMPO opened at $13.94 on Monday. The firm’s 50-day moving average price is $14.02 and its 200-day moving average price is $10.06. CompoSecure has a 52-week low of $4.61 and a 52-week high of $16.14. The company has a market cap of $1.23 billion, a PE ratio of -31.68, a PEG ratio of 1.13 and a beta of 0.76.

CompoSecure (NASDAQ:CMPOGet Free Report) last issued its quarterly earnings data on Friday, November 8th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.02). CompoSecure had a negative net margin of 5.63% and a negative return on equity of 14.87%. The company had revenue of $107.14 million for the quarter, compared to the consensus estimate of $105.11 million. During the same quarter last year, the company earned $0.24 EPS. As a group, equities research analysts anticipate that CompoSecure will post 1.02 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Adam Joseph Lowe sold 5,730 shares of the business’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of $12.05, for a total value of $69,046.50. Following the transaction, the insider now directly owns 1,292,219 shares in the company, valued at $15,571,238.95. The trade was a 0.44 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Jonathan Wilk sold 618,014 shares of the company’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total value of $4,666,005.70. Following the completion of the transaction, the chief executive officer now directly owns 618,013 shares of the company’s stock, valued at approximately $4,665,998.15. This trade represents a 50.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,641,727 shares of company stock worth $80,370,824. Company insiders own 74.99% of the company’s stock.

Institutional Trading of CompoSecure

Several institutional investors and hedge funds have recently added to or reduced their stakes in CMPO. Progeny 3 Inc. purchased a new stake in CompoSecure during the 3rd quarter valued at approximately $5,243,000. Verition Fund Management LLC purchased a new position in CompoSecure during the third quarter valued at $798,000. Woodson Capital Management LP bought a new position in shares of CompoSecure during the 3rd quarter valued at about $10,795,000. FORA Capital LLC purchased a new position in shares of CompoSecure during the third quarter valued at about $358,000. Finally, MetLife Investment Management LLC bought a new stake in shares of CompoSecure in the third quarter worth about $205,000. Institutional investors own 37.56% of the company’s stock.

CompoSecure Company Profile

(Get Free Report)

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.

Featured Stories

Analyst Recommendations for CompoSecure (NASDAQ:CMPO)

Receive News & Ratings for CompoSecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompoSecure and related companies with MarketBeat.com's FREE daily email newsletter.